Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06499805 · ClinicalTrials.gov registry record · NA
Barriers and Facilitators to OTC Hearing Aids Success
A NA study of Hearing Loss, Sensorineural and Presbycusis, sponsored by Yu-Hsiang Wu.
- Recruiting
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 2
- Study locations
NCT06499805: Recruiting NA study of Hearing Loss, Sensorineural and Presbycusis, sponsored by Yu-Hsiang Wu.
NCT06499805 is a NA study of Hearing Loss, Sensorineural and Presbycusis that is actively recruiting participants, run by Yu-Hsiang Wu. The registered enrollment target is 360 participants, below the 768-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (53% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06499805, a NA study of Hearing Loss, Sensorineural and Presbycusis, is actively recruiting participants, sponsored by Yu-Hsiang Wu.
- RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 2
- Study locations
Study Summary
Hearing aids can improve hearing, communication, and overall quality of life for people with hearing loss. However, not many people use hearing aids. A common reason is that hearing aids are expensive and hard to get. The traditional way to get hearing aids involves multiple visits to licensed audiologists for identifying hearing loss, customizing the aids, and ongoing maintenance. This traditional method is called the AUD pathway. Over-the-counter (OTC) hearing aids offer a different approach. They aim to make hearing aids more affordable and accessible, encouraging earlier use. In the OTC pathway, users diagnose their own hearing loss and fit and program the hearing aids themselves. Little is known about long-term effects of OTC hearing aids on users. This study aims to compare the experiences of people who choose the OTC pathway with those who choose the AUD pathway. It takes place in two locations: Iowa City, IA, and Nashville, TN. Participants, who have mild-to-moderate hearing loss, choose their preferred pathway and are followed for 12 months. In the OTC pathway, participants buy their hearing aids directly from OTC companies or retailers. In the AUD pathway, prescription hearing aids and fitting services are provided by audiology clinics at the University of Iowa and Vanderbilt University Medical Center. Participants are contacted 1, 6, and 12 months after starting to use their hearing aids. Researchers measure their satisfaction about hearing aids and other outcomes. If participants stop using their hearing aids, researchers assess their engagement with post-amplification hearing care. The results from both pathways are then compared.
Primary Outcome
The SADL is a questionnaire designed to measures subject's perceived hearing aid satisfaction. The score ranges from 1 (low satisfaction) to 7 (high satisfaction).
Conditions Studied
Interventions
- DEVICE Audiologist-based fitting
- DEVICE Over-the-counter fitting
Study Locations (2)
Iowa
- University of Iowa - Iowa City
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2025-03-15 |
| Est. Completion | 2029-04-01 |
| Phase | NA |
What NCT06499805 shows while recruiting
NCT06499805 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 768-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (53% lower).
The record links to 2 conditions, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 2 interventions - of which Audiologist-based fitting is the first listed.
NCT06499805 reports a single indexed study location in Iowa, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06499805 about?
NCT06499805 is a clinical study titled "Barriers and Facilitators to OTC Hearing Aids Success". Hearing aids can improve hearing, communication, and overall quality of life for people with hearing loss. However, not many people use hearing aids. A common reason is that hearing aids are expensive and hard to get. The traditional way to get hearing aids involves multiple visits to licensed audio...
What is the current status of trial NCT06499805?
This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2025-03-15. Estimated completion is 2029-04-01.
What conditions does trial NCT06499805 study?
This clinical trial studies the following conditions: Hearing Loss, Sensorineural, Presbycusis.
What interventions are being tested in trial NCT06499805?
The interventions under investigation include: Audiologist-based fitting (DEVICE), Over-the-counter fitting (DEVICE).
Who is sponsoring clinical trial NCT06499805?
This trial is sponsored by Yu-Hsiang Wu, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06499805 being conducted?
This trial has 2 study locations across Iowa, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss, Sensorineural
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06499805's enrollment target sits among peer trials
360 3rd of 20 higher than 18 of 20 other Hearing Loss, Sensorineural trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss, Sensorineural trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
-
Preschool Hearing Screening
RECRUITING · NA
-
Listening Effort in Cochlear Implant Users
RECRUITING · NA
-
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
RECRUITING · NA
-
Reading Outcomes in Children With Vestibular Loss
RECRUITING · NA
-
Evaluation of the Automated Integration of a Robotics and ECochG System for Use With Cochlear Implant Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI